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Abstract
Human Papillomavirus (HPV) is a group of more than 150 virus that can cause genital
warts and cancers of the oropharynx, cervix, vagina, vulva, penis, and anus. A preventive
vaccine currently exists that protects against seven oncogenic HPV strands and two strands that
cause genital warts. Current guidelines for HPV9 vaccination consist of a 2-dose series delivered
at 0 and 6 months for males and females ages 9-14, and a 3-dose series delivered at 0, 2, and 6
months for those ages 15-26.
While up-to-date (UTD) vaccination rates have increased across the Unites States, in
2017, only about 52.4% of adolescents in central city areas were vaccinated and those outside of
a metropolitan area lagged behind at 42.4%. In Kentucky specifically, the Cumberland Valley
Area Development Distract (CVADD) has among the highest incidence rates of both cervical
and head and neck cancers compared to the other area development districts in the state. As a
result, the Cumberland Valley District Health Department has decided to utilize their existing
relationships within Clay, Jackson, and Rockcastle County to implement a School-Based HPV9
Vaccination Clinic in the middle schools in the aforementioned counties.
The school-based clinic will begin with recruitment efforts at back-to-school events
within the counties involved. The clinics will be deployed in the schools with the first dose of the
series offered in August and September for five days each month, and the second dose will be
available in March and April. Retention efforts will include paper and text message reminders as
well as incentives for initiating and completing the 2-dose series.
Performance evaluation measures will be collected throughout the project; consent forms
will be completed by parents or guardians. A process evaluation will consist of clinic logs and
parent and guardian surveys to assess barriers to vaccination and their satisfaction with the
vaccine clinics. Primary outcome measures will be vaccination initiation and completion rates.
Secondary outcomes will focus on existing knowledge of HPV vaccination and biases associated
with the HPV vaccine and other immunizations; these will be assessed through the University of
North Carolina National Parent Survey. We hope that a School-Based HPV9 Vaccination Clinic
will increase UTD vaccination rates among youth in the CVADD, foster a passion that allows us
to expand this program to the remaining counties in the CVADD, and decrease HPV-associated
cancer rates in this region of Kentucky.
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Target Population and Need
Public Health Need
Human Papillomavirus (HPV) is a group of more than 150 related viruses. HPV can be
transmitted through skin-to-skin intimate contact. It is most commonly spread through
participating in oral, vaginal, or anal sex with someone who carries the virus. The transmission
of the virus is common partly because most infected individuals are asymptomatic. Some people
will develop symptoms years after being initially infected (i.e., persistent infection), while in
others, the virus clears on its own. Nearly all men and women become infected with HPV at
some point in their lives1.
When HPV does not clear on its own, it can cause detrimental health effects such as
genital warts and cancer. The types of cancers that HPV can cause include cancers of the
oropharynx, cervix, vulva, vagina, penis, and anus1. Each year, about 39,800 new cancer cases
are diagnosed in parts of the body where HPV can be found. Of those cases, HPV is the cause of
about 31,500 of the cancers, which equates to nearly 80% of cases. These cancers often have
relatively benign symptoms until they are advanced and hard to treat. Cervical cancer is the most
common HPV-associated cancer among women, and head and neck cancer is the most common
HPV-associated malignancy among men2.
The current Advisory Committee on Immunization Practices (ACIP)-recommended HPV
vaccine protects against infection from nine different HPV strands, seven of which cause
cervical, head and neck, vaginal, vulvar, or anal cancers and two of which cause genital warts.
HPV vaccination is indicated for both males and females who are 9-26 years old. For those aged
9-14, the vaccination is given in a 2-dose schedule wherein the second vaccine is given 6-12
months after the first dose3. For adolescents and young adults aged 15-26, 3-doses of the HPV
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vaccine is recommended; the second immunization is administered 2 months after the first, and
the third is given 6 months after the first shot4. In addition, the Food and Drug Administration
approved the use of the HPV9 vaccine for men and women aged 27-45 in October 2018;
vaccination guidelines for the older catch-up pool of adults are forthcoming from the ACIP5. The
HPV vaccine is up to 98% efficacious in preventing cervical cancer when the complete
vaccination series is administered at the appropriate age. However, barriers exist to receiving the
initial HPV vaccine as well as subsequent doses6. These barriers include, but are not limited to,
geographical and socioeconomic barriers to receiving preventive healthcare, absence of a strong
and consistent provider recommendation, and limited awareness of the existence of the vaccine
and HPV’s link to cancer. Additionally, the vaccine has been encountered with controversy due
to moral, religious, political, medical, gendered, and sociocultural beliefs 7.
Target Population
Since the introduction of the HPV vaccine in 2006, vaccination rates have increased
across the United States (U.S.) over the last 13 years, although they are still suboptimal
compared to other adolescent vaccine rates such as Tetanus-Diphtheria-Pertussis (Tdap) and
meningococcal conjugate8. About half of adolescents across the country were up-to-date (UTD)
on the HPV vaccine series in 2017 and about two-thirds had received at least the first dose of the
vaccine series. This is an increase of about 5 percentage points over the past 5 years9. However,
Kentucky adolescent male and females continue to lag behind the rest of the country when it
comes to UTD HPV vaccination rates (Figure 1).
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Figure 1: HPV Vaccination Rates in Kentucky versus the U.S., 2017

Lower rates of HPV vaccination in Kentucky could be due in part to the rural geography
of the state. In the U.S., those that live in a metropolitan statistical area have UTD HPV
vaccination rates as high as 52.4% when living in a central city. Those that live outside of a
metropolitan statistical area have vaccination rates of 42.4%. Due to this data, the Centers for
Disease Control and Prevention (CDC) has prioritized increasing HPV vaccination coverage
rates in rural communities9. The Appalachia region of the U.S., comprising 420 counties in 13
states, has higher incidence of all cancer types, including head and neck cancers and cervical
cancers, and lower HPV vaccination rates than its non-Appalachian counterparts10,11. As such,
we identified the Cumberland Valley Area Development District (CVADD) in Appalachian
Kentucky as a rural region in which there was a particular need for a School-Based HPV9
Vaccination Clinic. As mentioned previously, cervical and head and neck cancers are two of the
most common complications of HPV, and this district is amongst the highest in the state in both
cervical cancer incidence and mortality, as shown in Figure 2 and 3 respectively. The CVADD is
also amongst the highest ADD for oropharyngeal cancer rates, as shown in Figure 412.

Wiethorn

Figure 2: Cervical Cancer
Incidence Rates by KY County

7

Figure 3: Cervical Cancer
Mortality Rates by KY
County

Figure 4: Oropharyngeal Cancer Incidence Rates by KY County

A high rate of cervical cancer is a sentinel marker for many larger health care issues
indicating that there may be broader problems to access to care in these regions13. In addition,
CVADD scores lower on many social determinants of health compared to the entire state of
Kentucky. For example, from 2012-2016 about 85% of adults aged 25 or older have graduated
high school in Kentucky, while only about 73% of adults graduated high school within the
targeted district. The median household income within the state is $44,811; the median
household income within CVADD is more than $14,000 lower at $29,584. There was a higher
teen-birth rate in the CVADD than within the state of Kentucky from 2011-2015; 58 per 1,000
women aged 15-19 compared to 37, respectively14. Unfortunately, HPV vaccination data at the
county or ADD level is unavailable for Kentucky.
Although we hope to eventually implement our program throughout the entire CVADD,
we want to first pilot our program in three counties in the region in order to ensure program
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success and establish best practices. We have decided to utilize the existing relationship between
the Cumberland Valley District Health Department (CVDHD) and the counties in which it
represents – Jackson, Rockcastle, and Clay – in order to complete this pilot. Specifically, our
program will target the parents and guardians of middle-school aged children that attend public
middle schools within these three counties. Jackson County is home to Jackson County Middle
School (JCMS), Rockcastle County contains Rockcastle County Middle School (RCMS), and
Clay County has Clay County Middle School (CCMS). CCMS currently has 488 students
enrolled within their middle school that is comprised of two grades. We estimate that
approximately 250 students will be in the 7th grade each of the three years our program is
ongoing. JCMS currently has 448 students and RCMS has 664 students. We estimate that there
will be approximately 150 6th graders and 220 6th graders in the respective schools during the
length of our program. CCMS will participate in the program for three years, RCMS will
participate for 2 years, and JCMS for one. This would equate to 1,340 students with potential
participation in our School-Based HPV9 Vaccination Clinic over the three years. Recruitment
initiatives will begin at community Back-to-School events in which information will be provided
to parents and students regarding the HPV vaccine series. For more details, see the
“Recruitment” section on page 13 of this application. Recruitment and retention efforts will be
maintained through regular contact with students while at school.
Community Resources
The three counties in which our program will be implemented are served by the
Cumberland Valley District Health Department (CVDHD). Based on the success of our pilot
project, we hope to foster a relationship between the district health department and the other
independent county health departments in the CVADD in order to disseminate our project to
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other school settings. The CVDHD clinics offer Tdap, influenza, and Measles-Mumps-Rubella
(MMR) immunizations15. While they will need to be trained on HPV vaccination, specifically,
there are already staff that are trained to administer routine immunizations. The three counties
represented by the CVDHD also have their own local health departments in their respective
counties. These local health departments will provide resources, ideas, partners, and personnel to
help facilitate our program. Specifically, Healthy Clay, a coalition of organizations and
individuals working together to promote policy and community change for Clay County, has a
goal to increase school initiatives within their county. The Cumberland Valley District Cancer
Council (CVDCC) partners with the Kentucky Cancer Program and the Kentucky Cancer
Consortium, managed by the University of Kentucky (UK) Markey Cancer Center (MCC), to
discuss strategic planning to address local cancer problems and implement initiatives. The
CVDCC meets quarterly and consists of representatives from the county and district health
departments, hospitals, government agencies, healthcare providers, universities, businesses, labor
unions, schools, tobacco coalitions, and cancer survivors16. Additionally, Clay County
Community Hospital and Rockcastle Regional Hospital and Respiratory Care Center exist within
Clay and Rockcastle counties respectively14. Somerset Community College is located within this
ADD and offers an accelerated Licensed Practical Nurse (LPN) degree. Nurses from these
surrounding hospitals and new graduates from the community college can be hired or volunteer
to administer vaccinations to adolescents as part of our program.
Our School-Based HPV9 Vaccination Clinic will strengthen current relationships among
the health departments and the public middle schools within the counties. The proposed program
will enhance the number of adolescents that are reached by making it more convenient and
accessible for them to receive the complete vaccine series, and therefore prevent the spread of
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HPV and future development of HPV-associated cancers caused by the virus. We will work with
the aforementioned parties to assess changing community needs in order to adapt the program as
needed throughout the longevity of the grant to provide as many adolescents as possible the HPV
vaccine series.
Program Approach
School-Based HPV9 Vaccination Clinic
This program physically takes place within the school system and consists of
collaborations between the school and local health departments, private healthcare providers, and
community healthcare services. School-based vaccination programs include a variety of
activities, including at least two of the following components: (1) immunization education and
promotion, (2) assessment and tracking of vaccination status, (3) referral of under-immunized
school or childcare center attendees to vaccination providers, or (4) provision of vaccines17.
Other activities that have been implemented within these school-based programs are telephone
reminder systems, incentives to increase participation, and community advocacy18.
The timeline for school-based vaccination interventions vary based on the delivery
schedule of the immunizations given and the flexibility of the staff involved. When implemented
based on the HPV9 vaccine, those implementing the program would need to follow the standard
vaccination series based on the age of the youth (i.e., 2 doses for ages 9-14). Ideally, both doses
of the vaccine should be given during the school year in order to avoid a delay in vaccination
administration during the summer months. Our program will be based on iterations of schoolbased HPV vaccination conducted in Guilford, North Carolina and eastern Kentucky. In previous
iterations of school-based HPV vaccination programs such as in North Carolina, plans have been
implemented in a very fixed timeline, in which the first vaccine of the series would only be
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offered to students for one day. Then, the administrators, usually nurses, would come back two
and six months later to administer the subsequent doses19. The program has also been previously
implemented in a way in which students have the opportunity to receive their first dose over a
longer period. For example, as previously implemented in the Lake Cumberland region of
eastern Kentucky, the first dose of the vaccine series was offered from August through
November18. The second dose of the vaccine would, therefore, be available from March through
June.
Evidence-Base
Since 2009, vaccination programs in schools and organized childcare centers have been
recommended as evidence-based interventions on The Community Guide according to two
systematic analyses conducted by the Community Preventive Services Task Force17. Twentyseven studies were included in these analyses. Based on these analyses, vaccination rates
increased by a median of 47 percentage points whenever a school-based program was
implemented. The task force considered this to be strong evidence of effectiveness. In 23 of
these 27 programs, immunizations were provided on-site and included educational materials,
parental notification and consent forms, and additional opportunities to obtain the offered
vaccinations (e.g., a “make-up” schedule). Multi-component interventions could potentially
show increased effectiveness17.
Positive outcomes have also been discovered when specifically concentrating on the HPV
vaccine. The American Academy of Pediatrics conducted a review of 51 studies that shared a
focus of increasing HPV vaccination rates. Researchers found environmental interventions,
particularly school-based programs, to be the most successful. They stated that school-based
vaccination programs had two major advantages that contributed to their success when compared
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to other interventions: (1) increased access to the HPV vaccine and (2) that these interventions
were able to reach a large, diverse population without regards to individual access to
healthcare20. In addition, a study in North Carolina was conducted in which six middle schools
offered the 3-dose HPV vaccine series to their female students. Of the 181 girls who initiated the
vaccine series in the school-based clinics, 80% received all three doses of the vaccine19. A
similar school-based intervention completed in two high schools in eastern Kentucky, offered the
3-dose vaccine series to both female and male students. The vaccine series was initiated in these
school-based clinics by 70% of vaccine-naïve students. Of the 315 students that initiated the
vaccine series as part of the clinics, 88% completed all three doses of the vaccine18.
Setting
When completing our community needs and resource assessment, we identified three
counties within the CVADD with elevated HPV-associated cancer rates and a stable public
health infrastructure coordinated by the CVDHD. These three counties were Clay County,
Jackson County, and Rockcastle County. Each of these counties possess their own public health
department that works closely with the CVDHD. In addition, Clay and Rockcastle counties each
have a hospital, leading to additional healthcare resources as needed. Therefore, we decided to
implement our program within the public middle schools within these three counties: Clay
County Middle School (CCMS), Jackson County Middle School (JCMS), and Rockcastle
County Middle School (RCMS). Implementation in the middle schools allows us to access the
majority of 11-12 year-olds, all of whom are indicated to receive the HPV vaccination series
based on age.
Community Advisory Group
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Assembling an effective Community Advisory Group (CAG) is an essential part to
ensuring the success of this intervention. A School-Based HPV9 Vaccination Clinic will be
dependent on the school systems in the area as well as local agencies. In order to form this CAG,
we have identified key community members who are known in the area and are familiar with the
resources within the community. Inviting staff from the CVDHD will be essential in order to
expand upon vaccination programs already implemented in the region. Members of the school
boards and principals of the middle schools in which the program will be implemented are also
integral as these are the locations in which the intervention will take place. Parents will also be
invited in order to gauge their perspective on how to best reach most parents with regards to
giving consent for the vaccination series. A pediatrician, dentist, and pharmacist will be asked to
join the group to give their expertise on the safety, efficacy, and need for vaccines. A nurse will
also be in the group as nurses will be the primary staff administering the HPV vaccine. As one of
the largest expected barriers to this program is the negative connotation that administering the
vaccine will encourage teenagers to engage in risky sexual behavior, a prominent church leader
from the area will be recruited for the CAG; he will be beneficial to overcoming negative beliefs
about the cancer-preventing vaccine. Additionally, we will recruit two middle school
representatives to be a part of the CAG as the students will be the ones participating in the
intervention and their opinions and influence are essential to successful program implementation.
We will gather interest from the Student Government, Future Farmers of America, and
Fellowship of Christian Athletes presidents, captains of various sports teams, and leaders of the
drama club and band in order to spread awareness of the program.
The CAG will meet before the Back-to-School event each year and at the beginning of
each quarter in order to maintain relationships, provide updates, gain feedback, and assure that
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high quality healthcare is provided to both the participants and the community. By meeting this
frequently, we also hope to remain up-to-date in information regarding HPV, HPV-associated
cancers, and the HPV vaccine. The table below provides a list of the CAG members.
Table 1: Community Advisory Group Members
Lainey Greene, MPH
Margaret Robertson, MD
PD, Cumberland Valley Health Department
Pediatrician
Megan Wiggins
Paul Chang, PharmD
Member, Clay County School Board
Pharmacist
Michael Robin
Michaela Sherman, RN, BSN
Principal, RCMS
Nurse
To Be Named
Anastasia Kennedy, DMD
Parent, Jackson County Middle School
Dentist
Scott Wees
Eryne Wiethorn
Pastor
Program Coordinator
Gabriella Hamilton
To Be Named
SGA President, JCMS
Student Representative #2
Recruitment
Before we begin recruiting students to participate in the School-Based HPV9 Vaccination
Clinic, it is crucial that we address potential barriers to program implementation. One of the
barriers that we will likely face as we begin to recruit individuals is pushback from
parents/guardians who do not want their children to receive the vaccination due to negative
biases associated with it. This is why we plan to hold an educational event at the schools before
the recruitment process begins. This event will take place at community Back-to-School events
and be intended for students who are eligible to receive the vaccine series, their
parents/guardians, teachers and school administrators, and any other community member that is
interested in the information. These events are typically held after school and regular business
hours in order to encourage attendance. All of our community stakeholders will be present at the
event and are encouraged to invite guests who they know will benefit from HPV-related
education. At the event, local healthcare providers will lead a discussion about the safety and
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efficacy of the HPV vaccine. This will be followed by an update about the epidemiology of
HPV-associated health problems in the region from the director of the CVDHD. Next, a member
of the community living with cervical cancer will give her story to the audience. Our portion of
the event will end with an open forum in which parents/guardians, in particular, are encouraged
to ask any questions they feel need to be answered before giving their consent to HPV vaccine
administration in the school. We will also have representatives present at a booth throughout the
entirety of the Back-to-School event in order to answer these questions and give parents and
guardians the opportunity to fill out consent forms for their children and the pre-vaccination
parent survey.
The official recruitment process will begin with consent forms that will be distributed to
parents. The forms will be available at the Back- to-School Events and taken home with the
students in the 6th grade at RCMS and JCMS and the students in the 7th grade at CCMS on their
first day of class. The parents of 6th and 7th graders at the respective schools will also be sent a
link via email to complete the consent form online for convenience and to decrease the chance of
students losing consent forms either before or after giving them to their parents. Each consent
form will gather information on the student’s demographics, past HPV vaccination history, and
the form will ask for documentation of vaccine administration, if possible. The form will also ask
for both the consent of the parents to administer all doses of the HPV immunization that have not
yet been given to the students as well as consent to collect data from parents and guardians in the
form of pre- and post-vaccination surveys. If the student is given consent to receive the vaccine
series, the parent will be asked to provide the student’s insurance information, if applicable, in
order to bill for the vaccine doses. The consent forms will ask information that will assist the
nurses in filling out the vaccine administration questionnaire. The HPV9 Vaccine Parent Consent
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Form is available as Appendix A. All students who have returned parental consent forms, either
over the internet or in-person, will be asked for their assent before participating in our
intervention. The parent/guardian and/or student will have the option to discontinue participating
in the intervention at any time.
Implementation of Program
Our School-Based Clinic will operate with two different cycles available each year. In the
first cycle the 2-shot series will be available in August and March; the second cycle will be
available in September and April. The first immunization in the HPV vaccine series will be
available to the 6th or 7th graders who returned parental consent forms among the three selected
middle schools in August. Three nurses, the Program Coordinator (PC), and graduate-level
student research assistants will visit each school for a total of 5 days. During those days, students
will be able to visit the nurse’s office in order to receive their vaccination. They will be
encouraged to do this during either a lunch period, study hall, or any other free periods the
student may have so as not to interfere with their academic curriculum. Once they arrive, the
nurses will identify the student’s pre-filled vaccine administration questionnaire and be asked if
they feel sick that day in order to complete the form. Female students will also be asked if there
is any chance they are pregnant. Next, they will be sent to the nurses who will review the
questionnaire and administer the vaccination if deemed appropriate. The research assistants will
provide them with the current HPV Vaccine Information Statement (VIS), a raffle ticket to be
entered into a prize drawing, and a reminder slip for their next vaccination. They will also
document the date of the administration or any reasons the vaccine could not be administered.
The students will be asked to wait at least 15 minutes before leaving the nurse’s office in order to
be observed for syncope or other adverse reactions. If any adverse events do occur, these will be
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documented for program research purposes as well as documented officially through the FDA
Adverse Event Reporting System (FAERS). The PC will assist with observing the students and
overseeing the tasks of the graduate research assistants (GRA) in order to monitor for fidelity
and intervene in which the outlined processes are not followed.
All data collected as part of the School-Based Vaccination Clinic will be incorporated
into a holistic medical record for each adolescent who participates. This medical record will
contain their demographic information, primary care provider or pediatrician, vaccine
administration data, allergies, any adverse events that occur due to the HPV9 vaccine, and
insurance information. This will allow the implementation team to take a more comprehensive
approach to healthcare for the children involved and maintain better tracking records so fewer
students are lost to follow-up. Each record will be kept with the intent to share with the
pediatrician or healthcare provider who primarily cares for the child.
A similar process will take place six months later during March in order for students to
receive the second vaccine in the 2-dose series. Before the second dose is administered, the
parents/guardians and students will receive reminders of the upcoming vaccine administration.
These reminders are described in more detail under the “Retention” section on page 18. We will
repeat the process again with the first vaccination administered in September and the second in
April. The first year of the program will be a pilot period in which CCMS will receive the
intervention. During this period, the Program Director (PD) and PC will monitor closely for
program fidelity, assess areas in which quality improvement measures can be implemented, and
determine and mitigate barriers to program implementation. We will also make efforts to assess
that all program materials are medically accurate and age, culturally, and linguistically
appropriate for our adolescent and parent/guardian populations. In the second year of the grant,
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both CCMS and RCMS will have the School-Based HPV9 Vaccination Clinic intervention while
JCMS serves as the control. In the final year of program implementation, all three middle
schools will receive the intervention in following with the wait-list control method. Appendix B
contains calendars depicting when the immunizations will be available at each school.
Training of all members participating in program implementation will be conducted at the
beginning of each school year. These trainings will consist of topics such as appropriate ways to
interact with adolescents and parents/guardians, sensitivity and inclusivity training, HPV and its
associated vaccine education, and program implementation training. A shortened version of these
sessions will be conducted before the second semester of each school year for any new members
to the implementation team and as a refresher for existing members. Additionally, the nurses
administering the vaccine will have a more in-depth training concerning vaccine administration.
Impact
While it is difficult to determine the broader impact of the school-based vaccination
intervention for the HPV immunization within Kentucky and the U.S., there have been positive
data related to this type of public health intervention in both Canada and Australia. Women who
received the HPV vaccine as part of a school-based program in Alberta, Canada had fewer highgrade cervical abnormalities; these cervical abnormalities can often be the first step in
identifying a cervical cancer diagnosis. These women also had higher rates of cervical screening,
which may indicate that they exhibit a greater overall knowledge about their reproductive health.
However, these results only held their significance when all three doses of the vaccination were
administered21. In April of 2007, Australia commenced a nationwide vaccination program that
targeted 12- and 13-year old girls in schools, a “catch-up program” in schools for girls aged 1417, and a community-based program for women aged 18-26. A study in Victoria, Australia, in
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which they compared cervical abnormalities amongst girls who were eligible for vaccination in
the school-based program, found that a lower risk of any histologically confirmed high-grade
cervical abnormality was found for women who had received any HPV vaccination compared
with unvaccinated women. This effect was observed to be strongest in those that had received the
complete vaccination series22. Reduced incidence of cervical abnormalities will, hopefully, lead
to lower rates of cervical cancer within Australia and Canada. By building upon previous schoolbased vaccination interventions and adapting for local context, we hope to reproduce this impact
in the CVADD in Kentucky.
Retention
Retention is crucial for the success of a School-Based Vaccination Clinic for the HPV
Vaccine, as to receive maximum effectiveness of the vaccine, both doses have to be given at the
indicated interval. Most students participating in the intervention should already be attending
school almost every day, so the potential barrier to retention lies outside of not being able to
make it to the site of the intervention. However, the students must be reminded to report to the
vaccination clinic within the school on the appropriate days 6 months after their first vaccination.
One approach in which this will be addressed throughout the program is by sending reminders to
the student’s home highlighting the child’s next immunization due date. A paper reminder will
be sent home with each student approximately one week before their next vaccine in the series is
due. Additionally, parents will receive a text message approximately one day before their child is
due to receive their next vaccination. The idea behind both the text message and letter is that the
student and parent will each be notified by both reading the letter and receiving the text message
or having the messaged relayed to them. However, if the student never gives their
parent/guardian the letter or the parent/guardian forgets to tell their child about their scheduled
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vaccination, they each will each be reminded at least once. Although the students will be
encouraged to receive their vaccination in the School-Based Clinic, these reminders will also
provide information on how to end program participation if they wish to do so.
There will also be incentives in order to increase both participation and completion of the
program. If a student completes the entire vaccination series, they will be invited to participate in
a pizza party. This will be offered to all students whether they completed the entire series at the
School-Based Clinic or finished the series that was already started at a pediatrician’s office or
other health center. This is designed so that more students will want to participate in the program
through its entirety, rather than just receive one dose in the series. Additionally, students will
receive a raffle ticket for every HPV vaccination they receive at school. They will have the
opportunity to enter these raffle tickets to receive a basket in a prize drawing held on the day of
the pizza party. Some examples of baskets will include a movie basket, a Kentucky sports basket,
and a lotion/skin care basket. Our hope is that if peer leaders within the middle schools
participate in our program, they will allow other students to be exposed to our intervention
through observational modeling. Eventually, we believe that participating in the School-Based
HPV9 Vaccination Clinic can become the social norm, and those that did not participate in the
clinic initially will be motivated due to fear of missing out on the pizza party and chance to win
prize baskets.
While there will be many measures taken, such as text messages and paper reminders and
posters created and hung in school, in order to assure that students are reminded to participate
and engage in the School-Based Vaccination Clinic, we do foresee that some students may be
lost to follow-up. For example, adolescents may transfer schools due to different circumstances.
If the child transfers from one school that is participating in the school-based clinic to another,
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the child’s medical record will be transferred to his or her new school, and he or she will
continue to be followed. However, if the student transfers to a school that is not participating in
the intervention, this student will no longer be participating. In this instance, we will transfer the
child’s comprehensive medical record to his or her pediatrician if we received consent to do so.
This will, hopefully, encourage the pediatrician to complete the HPV vaccination series. If a
female student becomes pregnant before the first-dose of the vaccine series she will be ineligible
to participate in the program due to the vaccine being contraindicated in pregnant females. She
will be encouraged to receive the vaccine if she continues school after delivering her baby. If a
student becomes pregnant between the first- and second-dose of the vaccine, she will be
encouraged to receive the second vaccination after delivering her baby. The medical record will
assist the nursing staff in maintaining contact with these individuals. Finally, if a child
experiences a serious adverse reaction to the vaccine, it will be recorded in their medical record
and they will be contraindicated from receiving the subsequent dose of the vaccine.
We hope that the relationships built and fostered between the CVDHD, the education
provided to and passion instilled in the students, and support from the community due to the
School-Based Vaccination Clinics for the HPV9 Vaccine will allow the program to continue
after grant funding ends. If this program increases vaccination rates within the participating
counties, as we expect, we hope to expand the program to the remaining counties in the CVADD
in future years.
Adaptations
Our School-Based HPV9 Vaccination Clinic will consist of two minor adaptations from
the original interventions, as executed in Guilford County, North Carolina and the Lake
Cumberland region of Kentucky. The first is the way in which consent forms will be delivered to
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the students. Although paper forms will still be given to each student, parents will also be sent a
link in which they can fill out the form online and have the option to complete the forms during
the Back-to-School Events. The additional source of the consent form was added due to low
return rates of about 50% in a previous implementation of the program18. We hope to reach more
parents with the consent forms than in the original model. For example, if a student is given a
consent form at school but forgets or neglects to give it to their parent once they get home, this
new method of consent may help to increase consent rates. Secondly, we hope to eliminate the
barrier of turning the consent form in given a child may lose it or forget to turn it in at school.
The second adaptation that will be made to this program is that it will be offered to both
female and male students in a 2-dose series. This will be done in order to reflect the current
ACIP recommendations. By offering the vaccine to all students within the designated grades, we
hope to decrease the incidences of both cervical cancers and head and neck cancers, as well as
provide students with the additional benefits that the vaccine series has to offer. Moreover, we
hope to eliminate any gender biases that may have been associated with the HPV vaccine
previously.
Performance Measures and Evaluation
Process Evaluation
The program will utilize a process evaluation as recommended by the CDC in order to
determine if the program is being implemented as planned, determine any barriers to
implementation, and identify who is being reached by the program. The process evaluation will
also consist of a financial analysis to ensure that the cost of implementing the program remains
within the budget set forth in Appendix I. The data collected as part of the process evaluation
will be utilized to adapt the program as warranted.
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The consent forms that are sent to parents both electronically and in paper format will
contain basic demographic information that will be valuable to the study. In addition to asking
for vaccination consent, the form will ask for information regarding the adolescent’s sex, age,
insurance status (either insured, Medicaid/KCHIP, or no insurance), and prior doses of the HPV
vaccine18. Collecting information on these measures will allow the Evaluation Team to
determine groups of children that are being missed by the implementation strategy and identify
ways to include these groups of individuals in future semesters of the program and studies.
In order to ensure that the School-Based HPV9 Vaccination Clinics are implemented as
planned, both the Program Coordinator and the Assistant Coordinator will be present on all clinic
days. They will be well-trained in the program implementation process and ways to coursecorrect to guarantee fidelity of the program. In addition, the nurses will complete study logs
during and immediately following their experiences on clinic days. These logs will be used to
document clinic processes as they have been implemented rather than intended17. The Evaluation
Team will review these logs after each semester and compare their outputs to the intended
processes. The leadership team will plan additional training sessions if warranted based on the
results from the nurses’ logs.
After the School-Based Vaccination Clinics, two different post-surveys will be given to
parents and guardians of adolescents who returned consent forms. For those who gave consent
for their children to be vaccinated, the Post-Vaccination Parent/Guardian Survey will
characterize the reasons for which parents gave consent, prior barriers to vaccination, and
evaluation of the School-Based Vaccination Clinic. This survey is shown in Appendix C. Parents
will be encouraged to choose as many answers as they feel reasonable rather than limit
themselves to one answer choice. For those parents that declined to give vaccination consent, a
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separate Declined Consent Parent/Guardian Survey will be sent in order to determine barriers to
obtaining this consent19. This survey will consist of one question and is presented in Appendix
D. Again, parents will be encouraged to choose multiple answers if they feel it is necessary to
comprehensively answer the question. If there are a large number of parents who show
displeasure with the evaluation of the School-Based Vaccination Clinic or who decline consent
for vaccination, focus groups will be formed in order to further discuss this displeasure or
barriers to consent. The outcomes of these focus groups will be used to make adaptation to the
program and determine ways to overcome barriers to consent in future semesters.
Outcome Evaluation
In order to accurately assess the impact of the School-Based HPV9 Vaccination Clinic on
immunization rates and other outcomes, our study will operate as a cluster wait-list controlled
trial with a pilot period. Each school will serve as its own cluster. One school, CCMS, will serve
as the pilot and will be the only school participating in the program during the first year. One
additional school will be added to the study in each year thereafter, so that all schools will be
participating in the intervention in the final year of the study period.
The primary outcomes assessed during this study will be HPV9 vaccination initiation and
completion rates. These analyses will be conducted in two different manners. In the first analysis
of each, only those who returned consent forms will be assessed in order to provide a
straightforward interpretation of those choosing to participate in the program. A second analysis
will be conducted in which school-wide vaccination rates will be considered. If an adequate
amount of consent forms are returned to the schools with vaccination records, these materials
will be used in order to determine the baseline vaccination initiation and completion rates. If not
enough are returned, unfortunately, state-level data will have to be used as an estimate for these
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three counties. Each time a vaccine is given or a series is completed throughout the study, it will
be noted by the researchers. The post-program vaccination completion rates will be computed
based on baseline data and those given as part of the program18. Additionally, at the end of
program implementation, we will assess our data at the CVDHD and contact local health
departments and pediatrician offices to determine if more parents/guardians decided to have their
children vaccinated during the study period, but outside of our School-Based Vaccination Clinic.
Secondary outcomes assessed will include parents/guardians’ existing knowledge of HPV
vaccination and biases associated with the HPV vaccination and vaccinations in general. In order
to assess these measures an adaptation of the UNC National Parents Survey regarding questions
and concerns about HPV vaccination will be used. This survey was originally available online
and intended to compare communication methods about HPV9 vaccination; however, it includes
topics such as vaccination history, general vaccine attitudes, and HPV vaccine attitudes that
would be beneficial to assess as a part of our School-Based Vaccination Clinics23. Our iteration
of the parent/guardian survey is available in Appendix E.
The original survey items have been previously validated in studies of parents,
adolescents, and healthcare providers. Some items were adapted from other sources. The fully
developed survey was cognitively tested with a convenience sample of 16 parents/guardians of
adolescents who were aged 9 to 17 to confirm that participants understood items as intended.
Additionally, the instrument was pre-tested with 31 parents from the national panel.23
The measure will be available to the parents/guardians before vaccination at the Back-toSchool Events, as well as, with the consent packets both in paper format and electronically. The
clusters that are not receiving the intervention will serve as the baseline knowledge and control
for this portion of the study as they will not be present at Back-to-School Events yet. These
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parents/guardians will receive the survey as part of their adolescent’s packet at the beginning of
the school year. All parents/guardians who complete the survey will receive a $5 Walmart gift
card. The results of the surveys will be assessed for patterns and compared between the two
groups.
A logic model detailing our anticipated inputs, activities, and short- and long-term
outcomes is provided in Appendix G. Our leadership team formulated this model based on the
Health Belief Model, the theory we hope to follow during program implementation. We believe
we will address students’ and parents/guardians’ perceived susceptibility and severity of HPV
and perceived benefits of receiving a preventive HPV vaccine through education delivered
during back-to-school events. We anticipate decreasing perceived barriers to action by bringing
the clinic directly into the middle schools and assessing and intervening on additional barriers.
These factors will cue parents and guardians to action, and their children will participate in our
School-Based HPV9 Vaccination Clinic.
Capacity and Experience of the Applicant Organization
The mission of the Cumberland Valley District Health Department (CVDHD) is “to
improve and protect the health of individuals, families, and the public by implementing
preventative health services that focus on individual and population-based health promotion to
prevent disease, injury, and disability”15. This district health department has served the following
counties for 46 years: Bell, Clay, Harlan, Jackson, Knox, Laurel, Rockcastle, and Whitley. We
have long-standing coalitions with the Clay, Jackson, and Rockcastle County Health
Departments. We have existing school health initiatives in the aforementioned counties’ schools
that include having a health department nurse present to assist in preventive services such as
well-child screening and immunizations, in addition to referral services and assessment and
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treatment under physician collaborations and protocols. We confidently believe that the proposed
School-Based HPV9 Vaccination Clinic aligns with our vision to become a healthy community
in which the members have complete access to high quality care.
The department and its staff have experience implementing multiple programs within the
CVADD including the following: partnership with the Health Access Nurturing Development
Services (HANDS) program, syringe exchange programs, diabetes prevention and awareness
programs for children and adults, and preventive cancer screenings. More specifically, within the
Clay County, Jackson County, and Rockcastle County schools, they have hosted educational
events detailing physical activity, healthy eating, and hand hygiene and have, most recently,
provided filtered water-bottle filling stations. Most closely related to the Vaccination Clinic, we
provide Td, Tdap, influenza, MMR, and Hepatitis A vaccinations on-site.
We also have strong partnerships with the county health departments in which we serve
and have been actively involved in the training, implementation, and evaluation of multiple
programs with them. Healthy Clay is comprised of goals in which they hope to meet by 2022.
We have worked closely with them on these initiatives, one of them being to integrate healthy
living and wellness into the school curriculum. Our collaboration has built gardens at Clay
County schools to provide food and knowledge of healthy eating patterns. We have partnered
with Jackson County Healthy Communities to develop and enhance access to walking and biking
paths within the community. These paths include access to all Jackson County schools. We have
collaborated with the Rockcastle County Health Department to establish greenhouses in all
county schools and participate in Farm to Table programs. In addition, we partnered with them to
enroll students in RocketReader programs to increase reading speed and scores15. These prior
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initiatives and collaborations including the target population will encourage adolescents and
parents to participate in the CAG and foster support that may not have existed otherwise.
The CVDHD is led by Public Health Director Lainey Greene. Ms. Greene has experience
implementing programs in her current role such as the syringe exchange program and was the
lead in implementing the diabetes prevention program for children. In past roles, she has
implemented mentorship programs for children from grade school through high school. She
prides herself on having strong communication, education, and leadership skills and her past
experiences are evidence of her commitment to improving the health of children in Appalachia
Kentucky. For the past 4 years, Ms. Greene has managed the CVDHD budget of over $1,150,000
and serves as the supervisor of 38 committed employees.
In 2016, Rockcastle Regional Hospital and Respiratory Care Center performed a
Community Health Needs Assessment (CHNA) in accordance with the National Association of
County and City Health Officials’ recommendations of Rockcastle County and 14 surrounding
counties. As part of this assessment, CVDHD assisted in evaluating the 2013 strategic priorities
and developed the following 3 strategic priorities for the 2017-2019 fiscal years: cancer care and
prevention, health education, and mental health and substance abuse24. A School-Based HPV9
Vaccination Clinic will effectively fill a previous gap in the cancer care and prevention strategic
priority. Our program can partially be evaluated as part of the 2021 CHNA.
Additionally, the CVDHD does not and shall not discriminate on the basis of age,
disability, sex, race, color, national origin, religion, sexual orientation, gender identity, or reprisal
or retaliation for prior civil rights activity in any of its activities or operations. These activities
include hiring and firing of staff, selection of volunteers, and delivery of services. If
administration of CVDHD discovers that any member or collaborator on a project is in violation
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of this policy, that member shall be permanently terminated from the organization and banned
from the project.
Partnerships and Collaborations
The CVDHD has a long-lasting history of foundational partnerships, and the
collaboration on the proposed School-Based HP9V Vaccination Clinics will be no different. As
the program will physically take place within the middle schools in the region, one of the most
integral partnerships has already been developed with the middle schools in the area. The
principles of each middle school participating in this program have voiced their support of the
program through a letter of commitment. These letters of commitment are available in Appendix
H. In addition to providing the vaccination clinic services, representation from the CVDHD has
agreed to meet with the principals of each school to determine any additional services that can be
provided through them to increase the health of the students in the region.
However, the School-Based Vaccination Clinic will rely on many other partnerships.
Fortunately, many individuals and organizations have already voiced support and commitment to
collaboration with the CVDHD for implementation of the proposed program. The following
table illustrates those who have already given support and roles in implementation of the SchoolBased HPV9 Vaccination Clinic.
Table 2: Partnerships and Collaborations
Collaborative Organization
MCC Affiliate Networks

Representative/Liaison
Dr. Jacob Wilkins;
Oncologist at Rockcastle
Regional Hospital and
Respiratory Care Center

Role
MCC will assist with
determining baseline data for
HPV-associated cancer rates.
In addition, they are
responsible for ensuring that
all education regarding HPVassociated cancers provided
to students and
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Kentucky Health
Departments Association
(KHDA)

Eryne Wiethorn, MPH;
Member, PC, and CAG
member

American Academy of
Pediatrics (AAP)

Dr. Margaret Roberts;
Pediatrician at Baptist Health
Corbin Primary Care and
CAG member

American Nurses Association
(ANA)

Michaela Sherman; RN,
BSN, AC, and CAG member

Kentucky Cancer Consortium
(KCC)

Brooke Dean; Cumberland
Valley District Cancer

parents/guardians is
medically accurate and
current. They will have
access to all outcome data at
the conclusion of the
intervention period and have
the ability to track long-term
outcomes.
KHDA will provide resources
and ideas as needed to
implement the program to the
highest fidelity and
accessibility to our
population. They will assist in
gathering and confirming
state-level data for measures
and will have access to all
outcomes data at the
conclusion of the program.
The Kentucky Chapter
currently has an initiative
titled “HPV Focus”. AAP
will be responsible for
assuring that all materials
covered in vaccine
administration training is
appropriate practice for our
adolescent population and
that adequate education is
provided to all staff involved
in clinics. At the end of our
program, we will provide
them with the entirety of our
outcome data.
Responsible for
communicating any updates
to nursing policy or best
practices in regard to vaccine
administration and HPV
vaccination to clinic nursing
staff and leadership. In return,
all nurses involved with the
program will be paid ANA
members.
Brooke has personally agreed
to tell her story at Back-to-
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Program Representative and
survivor of cervical cancer

Student Government
Association

UK College of Public Health

Kentucky Rural Health
Association (KRHA)

Clay, Jackson, and
Rockcastle County School
Boards

Project Management
Leadership

School recruitment events
and the KCC will assist with
recruitment efforts. The
CVDHD will continue to
advertise all KCC events in
the region, whether they
relate closely to the proposed
program or not.
Gabriella Hamilton; SGA
SGA at each school will be
President at Jackson County
responsible for designing
Middle School, CAG
posters and determining
member, and student
appropriate engagement
activities and times to foster
student participation in the
School-Based Vaccination
Clinics.
Nicholas West, PhD;
UK College of Public Health
Associate Professor in the
will assist in recruitment
Department of Health,
efforts of two graduate-level
Behavior & Society
students who are interested in
and capable of becoming
research assistants for this
project.
Dr. Christopher Jones;
KRHA will ensure that all
Member and Primary Care
materials are culturally
Physician at White House
appropriate for our rural
Clinic in McKee, KY
population of both
adolescents and
parents/guardians. They will
partner with us to provide
contact information to
adolescents without a Primary
Care Provider or pediatrician.
Megan Wiggins; Clay County The school boards will assist
School Board Vice President, with assessing and
mother, and CAG member
overcoming barriers to
program implementation and
negative connotations
associated with the HPV
vaccine.
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To meet the goals set forth above, the School-Based HPV9 Vaccination Clinic will be
directed by a set of three leaders. The leaders of the program will consist of the Program
Director, Program Coordinator, and Assistant Coordinator. They will have a presence at all of
the school-based clinics and ensure that the program is implemented and evaluated as planned.
They will also make any decisions in regard to program implementation and evaluation in order
to accurately represent our CAG.
Program Director
Lainey Greene, MPH, will serve as the Program Director (PD) of the School-Based
HPV9 Vaccination Clinic. Ms. Lainey Greene earned her Master of Public Health (MPH) Degree
from Eastern Kentucky University in 2011. She currently serves as the Public Health Director for
the CVDHD and has over 10 years of experience working at the Madison County Health
Department in various capacities. Her primary responsibilities will include program design,
implementation, and evaluation. Additionally, she will be accountable for financial supervision
of the program.
Program Coordinator
Eryne Wiethorn, MPH, will serve as the Program Coordinator (PC) for our clinics. She
received her MPH from UK and serves as the current Program Analyst of the CVDHD. She has
previous experience in implementing and analyzing the district health department’s current
initiatives in school health and clinical services, including immunizations. Ms. Wiethorn will
assist the PD in the design, implementation, and evaluation of the program. Her primary
responsibilities will include (1) day-to-day oversight of the program, (2) training of the assistant
coordinator and additional staff, (3) data collection, (4) maintaining a relationship with the key
stakeholders in the region, and (5) organizing quarterly update meetings with the CAG.
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Assistant Coordinator
Michaela Sherman, RN, BSN, will operate as the Assistant Coordinator (AC) for our
program. She earned her Bachelor of Science in Nursing at UK and has three years of experience
working as a nurse at MCC. Currently, she serves as a nurse at the CVDHD. In this role, she
oversees the school health program in which local health department nurses are available for
students to assist with acute illnesses and long-term management of special healthcare needs.
Ms. Sherman will assist the PC in the day-to-day oversight of the program. Primary
responsibilities will include (1) training of all nurses involved with vaccine administration, (2)
administration of vaccines during clinic hours, and (3) coordination of recruitment and retention
activities.
Staff
Graduate Research Assistants (GRA)
The School-Based HPV9 Vaccination Clinic will not be possible without additional
support staff members. Two MPH GRAs will be hired to help implement the program. They will
be present during the clinics and provide students with the VIS, raffle tickets, and reminder slips,
as well as, document vaccine administration information. They will assist with data collection of
the consent forms and vaccine administration. These MPH students will be recruited through
recommendations with our partners at the UK College of Public Health. Before implementation
of the School-Based HPV9 Vaccination Clinics, they will receive data collection training and
complete required human subjects protection training. After each clinic, or once per semester,
these students will meet individually with the PC and one of their professors to assess any
learning needs and areas for professional development.
Nurses
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Additionally, the local health department nurses, whom already have a relationship with
the schools, will be recruited to facilitate the HPV vaccination clinics before program
implementation. Their purpose will be to review the vaccine questionnaires for appropriateness
of administration and administer vaccinations to the students. They will also assist the AC with
retention activities. As these nurses will have the primary responsibility for administering
vaccinations, they will receive extensive training before program implementation. This training
will be facilitated by the AC. Various healthcare professionals will conduct the training to
educate them on HPV, HPV vaccination, and program implementation. They will also receive
sensitivity training for the specific patient population. At the end of their training, they will be
required to pass a short test in order to ensure safe administration procedures.
Biostatistician
A biostatistician will be hired to serve as the primary data analyst during the month of
July before data collection. He or she will be responsible for analyzing data collected from the
vaccine consent forms and communicating the interpretations of the data with the PD and PC.
Once the program begins, the PD will conduct biweekly phone conferences with the statistician
to assure that he or she is on task and to obtain any updates.
All leadership and staff members will complete appropriate training in order to comply
with HIPAA regulations and to facilitate appropriate interactions with students. The PD will
ensure that all leadership and staff members of the program are adequately compensated for their
time and efforts to ensure minimal staff turnover
throughout the duration of our project. The figure
below shows the project management structure for
the School-Based HPV9 Vaccination Clinics.

Figure 5: Project Management Structure
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Appendices
Appendix A: HPV9 Vaccine Parental Consent Form
Human Papillomavirus (HPV) Vaccine Consent Form
Student’s Name_____________________________________
Child Identifies as:

Age_____

____ White ____ African American/Black
____ Asian

____ Latino/Hispanic

Gender_______

____ American Indian

____ Other: ____________

Please complete the appropriate section.
ACCEPT VACCINATION
____ My child has not received the HPV vaccine. Yes, I consent to my child being fully
protected by receiving the entire two (2) dose series. I understand this will be administered at
no cost to me or my child.
____ My child has already received the HPV vaccine but has not completed the recommended
two (2) doses. I understand 2 doses are required for full protection. Yes, I consent for the
remaining dose. I understand this will be administered at no cost to me or my child. The dates
of the previous dose is: __________
Does your child have an allergy to medications, foods, or latex?
____ Yes ____ No
If yes, please specify: _________________________________________________
Does your child have an allergy or hypersensitivity to yeast?
____ Yes ____ No
Has your child had a serious reaction to a vaccination in the past?
____ Yes ____ No
(For Females) Is your child pregnant or is there a chance she could
____ Yes ____ No
become pregnant within the next month?
My child: ____ does not have insurance ____ has private insurance that covers vaccinations
____ is enrolled in Kentucky Medicaid ____is underinsured
By signing this, I am consenting to my child receiving the recommended three doses or the remaining
doses required for full protection. I have read or had read to me information about the HPV vaccine. I
have been given the Vaccine Information Statement for the vaccine. I had a chance to ask questions
which were answered to my satisfaction. I believe I understand the benefits and the risk of the vaccine
to be administered and ask that the vaccine be given to my child. I also consent to care which may
include, assessments, treatment, first-aid, over the counter medicine, and any other health service
given to me/my child by staff or agents of the Cumberland Valley District Health Department. I
understand no guarantees are being made as to the effect of any exam or treatment on me/my child. I
like-wise release the staff from any liability related to the administering of the above vaccine to my
child so long as the responsibility is discharged according to the manufacturer's instructions. I
authorize the school health clinic to release medical information about my child, as permitted by the
Health Insurance and Portability and Accountability Act of 1996 (HIPAA), to his/her primary care
provider and to share pertinent medical information (history of allergies or significant medical history)
with school staff who may need to provide care to my child in an emergency or in order to meet school
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reporting requirements. I understand that the sharing of this information is on a need to know basis
only. If my child has Medicaid or KCHIP or private insurance, I also authorize the school clinic to
release this information to these parties so that they can be billed for visits to the school clinic. This
permission can be revoked at any time, and will expire one year from the date signed.

Signed (Parent/Guardian)_______________

Printed _______________

Date__________

DECLINE VACCINATION

____ My child has already completed the recommended two (2) dose series and is fully
protected. No, I do not consent my child to participate in the vaccination clinic.

Signed (Parent/Guardian)_______________

Printed _______________

Date__________

____ No, I do not consent my child to receive the HPV vaccination series as part of the
vaccination clinic.

By signing this, I admit that I have read the Vaccine Information Sheet from the Centers for Disease
Control and Prevention explaining the vaccine and the disease it prevents. I have had the opportunity
to discuss this with my child’s school nurse and Program Coordinator, who have answered all of my
questions regarding the recommended vaccine. I understand the purpose and the need for and the risks
and benefits of the recommended vaccine. I know that failure to follow the recommendations about
vaccination may endanger the health or life of my child and others with which my child might come in
contact. I know that I can change my mind and accept the vaccination for my child in the future.

Signed (Parent/Guardian) _______________

Printed _______________

Date __________

If you require additional information before giving consent, please contact Eryne Wiethorn,
the Program Coordinator at eryne.wiethorn@cvhdh.gov or (606)779-3373.
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Appendix B: Program Calendars
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Appendix C: Post-Vaccination Parent Survey
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School-Based HPV9 Vaccination Clinic Post-Vaccination Parent/Guardian Survey
Why did you decide to allow your child to be vaccinated for HPV? (check all that apply)
____

It is the best way to prevent HPV infection

____

The potential health consequences of HPV infection could be serious.

____

My child’s healthcare provider recommended it.

____

My child is, or will be, at risk of acquiring HPV.

Why did you decide to not get your child HPV vaccinated previously? (check all that apply)
____

HPV vaccine is too expensive.

____

I didn’t know enough about HPV.

____

It was inconvenient to make two appointments to receive all the shots.

____

I didn't know enough about HPV vaccine.

____

HPV vaccine is not mandatory for school entry.

Feedback about the School-Based HPV9 Vaccination Clinic. (check all the apply)
____

I was pleased with the overall experience.

____

I would like to see more partnerships between the school system and district health
department in the future.
I would recommend School-Based Vaccination Clinics to family and friends.

____
____
____

I felt that the information and consent packet was sufficient to make an informed
decision.
The other information I received from this project helped me to make an informed
decision.

Appendix D: Declined Consent Parent Survey
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School-Based HPV Vaccination Clinic Declined Consent Parent/Guardian Survey
Why did you choose not to have your child participate in the School-Based HPV Vaccination
Clinic? (check all that apply)
____ My child already received all three doses of the HPV vaccine.
____

I am not sure the HPV vaccine is safe and effective.

____

I am worried about potential side effects of the HPV vaccine.

____

I do not believe my child needs the HPV vaccine.

____

I need more information before making a decision about the HPV vaccine.

____

Other: _______________________________________________________________

Appendix E: UNC National Parent Survey – Adapted
Parent/Guardian HPV Vaccination Survey
Please mark one option for each answer.
1. How many children do you have between the ages of 9-17 in your household?

____

2. How many shots of the HPV vaccine has your
____ None ____ 1 ____ 2 ____ 3
youngest child between the ages of 9-17 had?
3. What age did your youngest child between the
____ 9 _____ 10 ____ 11 ____ 12
ages of 9-17 receive the HPV vaccine?
____ 13 ____ 14 _____ 15 ____ 16 ____ 17
4. Vaccines are necessary to protect the health of middle school children.
____

Strongly agree

____

Somewhat disagree

____

Somewhat agree

____

Strongly disagree

____

Neither agree nor disagree

5. Vaccines do a good job in preventing the diseases they are intended to prevent.
____

Strongly agree

____

Somewhat disagree

____

Somewhat agree

____

Strongly disagree
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____

Neither agree nor disagree

6. If I do not vaccinate my child, he or she may get a disease such as meningitis and cause
others to get the disease.
____
Strongly agree
____ Somewhat disagree
____

Somewhat agree

____

Neither agree nor disagree

____

Strongly disagree

7. The HPV Vaccine may cause lasting health problems.
____

Strongly agree

____

Somewhat disagree

____

Somewhat agree

____

Strongly disagree

____

Neither agree nor disagree

8. I do not have enough information about the HPV vaccine to decide whether to give it to my
child.
____
Strongly agree
____ Somewhat disagree
____

Somewhat agree

____

Neither agree nor disagree

____

Strongly disagree

9. The HPV vaccine is effective in preventing several cancers.
____

Strongly agree

____

Somewhat disagree

____

Somewhat agree

____

Strongly disagree

____

Neither agree nor disagree

10. It would be hard to find a provider or clinic where I can afford the HPV vaccine for my
child.
____
Strongly agree
____
Somewhat disagree
____

Somewhat agree

____

Neither agree nor disagree

____

Strongly disagree

11. Other parents in my community are getting their children the HPV vaccine.
____

Strongly agree

____

Somewhat disagree
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____

Somewhat agree

____

Neither agree nor disagree

____

Strongly disagree

12. Most people who are important to me would support getting the HPV vaccine for my child.
____

Strongly agree

____

Somewhat disagree

____

Somewhat agree

____

Strongly disagree

____

Neither agree nor disagree

13. How many vaccines do you think would be safe for a one-year old to get at a single checkup?
____
None
____
3 vaccines
____

1 vaccine

____

4 vaccines

____

2 vaccine

____

5 or more vaccines

14. How many vaccines do you think would be safe for an eleven-year old to get at a single
check-up?
____
None
____
3 vaccines
____

1 vaccine

____

4 vaccines

____

2 vaccine

____

5 or more vaccines

15. Imagine you agree to get your child the three vaccines they are due for: meningitis, HPV
vaccine, Tdap vaccine. Would you prefer…
____ Get all 3 vaccine at one visit
____
Spread the vaccines across multiple visits
____

Get whatever the doctor or healthcare provider recommends

16. Imagine your child gets the first dose of HPV vaccine today. When would you prefer he or
she get the next dose?
____
As soon as is recommended
____ At their next check-up

Appendix F: Gantt Chart
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Appendix G: Logic Model
Evaluation of Outcomes and Processes
Inputs
Partners
-

-

-

Schools: principals, school
nurses, parents, students,
school boards
Health departments: local
departments, development
district department
Implementation team,
leadership, and staff
Community Action Group
MCC, AAP, ANA, KCC,
KRHA
SGA and other student
organizations

Budget
-

Funds for materials,
vaccinations, and incentives

Resources
-

KCR
MMWR
CDC
Immunization records

Activities
Preparation
- Train school nurses
and intervention staff
- Hold Back-to-School
Event
- Provide student
education

Short-Term Outputs

Long-Term Outcomes

Increase student and
parent knowledge about
HPV and the vaccine

Increase the initiation
and completion rates of
HPV-9 vaccination

Reduce barriers to the
HPV vaccine

Reduce the incidence
and mortality of genital
warts and HPV-related
cancers

Intervention
- Consent packets and
student surveys
- Conduct vaccination
clinics
- Collect data and send
reminders
- Send postvaccination surveys

Contextual Conditions (e.g. national recommendations, media reports)

Appendix H: Letters of Commitment for the Proposed Program

Wiethorn 49
A. Letter of Commitment from Mr. Steven Diamond, Clay County Middle School Principal
B. Letter of Commitment from Dr. Adam Kirby, Jackson County Middle School Principal
C. Letter of Commitment from Mr. Michael Robin, Rockcastle County Middle School
Principal
Appendix I: Budget and Justification
The Grant budget is proposed for July 1, 2019-June 30, 2022.
Anticipated Enrollment
As outlined in the “Target Population and Need” section on page 3, our program has the
potential to reach approximately 1,340 students over the three-year course of this grant.
However, we assume that 40% of our students will be UTD on their HPV vaccination before
implementation and that many students will not return consent forms. Therefore, we anticipate
that 50% of eligible students will enroll in the program, or about 670 students. On average, we
estimate that about 225 students will enroll in our School-Based HPV9 Vaccination Clinic each
year. More specifically, we estimate that 125 students will be enrolled in Year 1, 235 students
will be enrolled in Year 2, and 310 will be enrolled in Year 3. This will allow us to utilize
$250,000 per year, or $750,000 total over the duration of the grant.
Personnel
Table 3: Personnel Budget Year 1
Year 1

Effort

Salary

Fringe

Total

Program Director

20.00%

$100,000

$20,000

$5,486

$25,486

Program Coordinator

70.00%

$80,000

$56,000

$16,226

$72,226

Assistant Coordinator

50.00%

$60,000

$30,000

$9,465

$39,465

MPH GRA 1

33.00%

$32,000

$10,560

$4,283

$14,843
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MPH GRA 2

33.00%

$32,000

$10,560

$4,283

$14,843

CCMS Nurse

6.00%

$40,000

$2,400

$881

$3,281

RCMS Nurse

0%

$40,000

$0

$0

$0

JCMS Nurse

0%

$40,000

$0

$0

$0

Biostatistician

5.00%

$35,000

$1,750

$681

$2,431

$131,370

$41,305

$172,675

Fringe

Total

Total

Table 4: Personnel Budget Year 2
Year 2

Effort

Salary

Program Director

10.00%

$103,000

$10,300

$2,825

$13,125

Program Coordinator

80.00%

$82,400

$65,920

$19,100

$85,020

Assistant Coordinator

50.00%

$61,800

$30,900

$9,749

$40,649

MPH GRA 1

33.00%

$32,960

$10,877

$4,412

$15,289

MPH GRA 2

33.00%

$32,960

$10,877

$4,412

$15,289

CCMS Nurse

6.00%

$41,200

$2,472

$907

$3,379

RCMS Nurse

6.00%

$41,200

$2,472

$907

$3,379

JCMS Nurse

0%

$40,000

$0

$0

$0

Biostatistician

5.00%

$36,050

$1,803

$701

$3,379

$135,621

$43,013

$178,634

Fringe

Total

Total

Table 5: Personnel Budget Year 3
Year 3
Program Director

Effort
10.00%

Salary
$106,090

$10,609

$2,910

$13,519
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Program Coordinator

80.00%

$84,872

$67,898

$19,673

$87,571

Assistant Coordinator

50.00%

$63,654

$31,827

$10,041

$41,868

MPH GRA 1

40.00%

$33,949

$13,580

$5,508

$19,088

MPH GRA 2

40.00%

$33,949

$13,580

$5,508

$19,088

CCMS Nurse

6.00%

$42,436

$2,546

$934

$3,481

RCMS Nurse

6.00%

$42,436

$2,546

$934

$3,481

JCMS Nurse

6.00%

$42,436

$2,546

$934

$3,481

Biostatistician

10.00%

$37,132

$3,713

$1,445

$5,158

$148,845

$47,887

$196,732

Total

The majority of the budget for the School-Based HPV9 Vaccination Clinic will be
dedicated to the salaries and other benefits of the personnel implementing the program. While
the PD will be charged with overseeing the design, implementation, and evaluation of the
program, as well as have all financial responsibilities, she will have few hands-on responsibilities
of implementation. We expect her to spend only 20% of her time on our project in Year 1 and
10% of her time in the two subsequent years. The PC will have the direct oversight, data
collection, and training responsibilities. Therefore, we expect her to spend the majority of her
time on our project. The AC will be expected to be present on all clinic days and will assist in the
retention process by contacting students and their parents to remind them to complete the second
dose of the vaccine series. She will also be responsible for training all other nurses involved in
the program. Therefore, we expect the AC to spend 100% of her time on this program for 6
months out of each year.

Wiethorn 52
The MPH GRAs will be hired for 20 hours per week. These assistants will be present at
the clinics in order to distribute VIS, incentive tickets, and reminder slips and document vaccine
administration. They will also aid in data collection and interpretation year-round. The local
health department nurses that are already affiliated with each of the schools included participate
in the program by administering vaccines to appropriate students. The clinics will be at each
school for 20 days out of the year. By including time for training, we will reimburse them for
almost one-month’s salary. We expect the additional nurse to be present during all clinic days at
each school to assist in the previously mentioned activities. Additionally, he/she will assist the
AC with reminders for second doses. We will also hire a biostatistician to assist in analyzing our
data. We will expect this person to spend approximately 5% of their time on our project during
Years 1 and 2. However, we would like the statistician to spend more time during Year 3 in order
for us to draw final conclusions for our project.
Equipment
The only equipment that we plan on purchasing for our intervention is two School-Based
HPV9 Vaccination Clinic laptops that are to be used solely for the purpose of our project. We
will purchase two MacBook Airs, priced at $1,100 each for a total of $2,200.
Supplies

Number
PROGRAM SUPPLIES
HPV$$609
100 (Y1);
Vaccine
190 (Y2);
250 (Y3)
Needles
250 (Y1);
470 (Y2);
620 (Y3)
Gloves
500 (Y1);
940 (Y2)
1,240 (Y3)

Table 6: Supply Budget
Unit Cost
Year 1
$168.10

Year 2

Year 3

$16,810

$31,939

$42,025

$0.20

$50

$94

$124

$0.12

$60

$112.80

$148.80
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Bandages

Alcohol Swabs

Cotton Balls

Hand Sanitizer

Paper
Ink
Raffle Ticket

Reminder Cards

INCENTIVES
Gift Cards for
Parents
Basket Materials

250 (Y1);
470 (Y2);
620 (Y3)
250 (Y1);
470 (Y2);
620 (Y3)
250 (Y1);
470 (Y2);
620 (Y3)
12 (Y1); 24
(Y2); 36
(Y3)
1,860 sheets
per year
6 cartons per
year
250 (Y1);
470 (Y2);
620 (Y3)
125 (Y1);
235 (Y2);
310 (Y3)

$0.10

$25

$47

$62

$0.16

$40

$75.20

$99.20

$0.01

$2.50

$4.70

$6.20

$3

$36

$72

$108

1,500 for $28

$56

$56

$28

$120

$120

$120

$10

$0

$0

$6.25

$11.75

$15.50

$20
2,000 for $10

$0.05

620 per year

$5

$3,100

$3,100

$3,100

3 (Y1); 6
(Y2); 9 (Y3)
Pizza Party
1 (Y1); 2
Materials
(Y2); 3 (Y3)
RECRUITMENT SUPPLIES
Totals
Total

$50

$150

$300

$450

$200

$200

$400

$600

$1,000
$21,666

$500
$36,832

$500
$47,387
$105,885

A substantial portion of the funds needed for this program will be used in order to acquire
the HPV9 vaccines themselves. While we are estimating that 125 students will utilize our clinics
in Year 1, 235 in Year 2, and 310 in Year 3, we estimate that at least 39% of these students will
be enrolled in Kentucky Children’s Health Insurance Program (KCHIP), as this is the current
national coverage rate25.We will bill KCHIP for our services and estimate the ability to bill for
approximately 20% of additional vaccines through private insurance companies. Therefore, we
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only estimate to accrue the cost of about 100 vaccines in Year 1, 190 vaccines in Year 2, and 250
vaccines in Year 3. We will also need to purchase all other medical supplies (gloves, bandages,
needles, etc.) needed to administer the vaccines. While we will not have to purchase a printer, we
will supply our own paper and ink in order to print the VIS, reminder cards, consent forms, and
surveys. Additionally, we will budget a set amount of money for raffle tickets, prize baskets, and
pizza parties each year for incentive purposes. We will budget $3,100 per year to put towards $5
Walmart gift cards for parents or guardians who return both the pre-clinic survey and post-clinic
survey in addition to the consent form. We will also reserve money to be used for recruitment
activities. We expect to spend about double the funds on recruitment during the first year
compared to the two subsequent years.
Travel
Table 7: Travel Budget
Year 1
Local Travel

Year 2

Year 3

$300

$300

$300

APHA Meeting Registration

$1,000

$1,000

$1,000

Airfare

$1,000

$1,000

$1,000

Overnight

$1,000

$1,000

$1,000

Total

$3,300

$3,300

$3,300

The leadership and staff members of our program will be required to travel locally to the
schools in order to implement the program and attend trainings. The schools furthest from each
other are Rockcastle County Middle School and Clay County Middle School with a distance of
44 miles. The MPH GRAs will also be required to travel from UK to the CVADD, totaling about
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96 miles, in order to participate about 5 times per year. We will reimburse mileage based on the
standard mileage rates of 54.5 cents per mile. We will reserve $3,000 per year in our budget for
these purposes.
Additionally, we plan to have two leadership members attend the American Public Health
Association annual conference. We will budget for the members’ registration, travel, and lodging
fees. We are estimating that the registration fees will be about $500 each, airfare will be $500
each, and each room will cost about $250 per night for two nights.
Training
Table 8: Training Budget
Year 1
Fee for service

Year 2

Year 3

$1,500

$1,500

$1,500

Room

$400

$400

$400

Nurse-specific training

$750

$750

$750

Food

$300

$300

$300

Total

$2,950

$2,950

$2,950

In order to ensure that those implementing the program are educated on the program in its
entirety, we will hold a 4-hour training event before the recruitment process for the program
begins. We anticipate spending $50/hour in order to rent a room to host this event. We will also
provide a meal for all who attend as well as reimburse them for their time. We will hold a similar
2-hour abbreviated training event before the school year starts in order to ensure fidelity of the
program over time. Additionally, we will hold a nurse-specific hour-long training session at the
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beginning of each school year. This training will cover what the nurses should be reviewing from
the vaccination questionnaires and proper administration techniques.
Other Expenses
In addition, tuition is requested for the two GRAs in agreement with UK’s policy. Tuition
estimates have been calculated based on current in-state rates and are projected to increase by
approximately 10% each year. Quarterly, we will meet with the CAG in order to discuss our
progress and share ideas, thoughts, and concerns regarding HPV, HPV9 vaccination, and our
School-Based Clinic. We will budget $15/person for meals at each of these meetings.
Final Budget Sheet
Table 9: Cumulative Budget Sheet
Category
Personnel

Year 1

Year 2

Year 3

$131,370

$135,621

$148,845

Fringe

$41,305

$43,013

$47,887

Tuition

$22,000

$24,200

$26,620

$2,200

$0

$0

$21,666

$36,832

$47,387

Travel

$3,300

$3,300

$3,300

Training

$2,950

$2,950

$2,950

$720

$720

$720

$225,511

$246,636

$277,709

Equipment
Supplies

CAG Meetings
Totals
Total

$749,856

